Cipla Limited (NSE: CIPLA) partners with S BP Group for exclusive licensing of best-in-class HER2 bispecific ADC, aiming to enhance breast cancer treatment i.
Orchid Pharma Limited (ORCHPHARMA) signs licensing agreement with Pharmasyntez to commercialize Exblifep® in Russia, targeting USD 178 million over 10 years.